Suppr超能文献

对比住院体外心肺复苏与体外膜肺氧合患者标准心脏治疗组:单机构8年经验。

Comparing in-patient extracorporeal cardiopulmonary resuscitation to standard cardiac treatment group of extracorporeal membrane oxygenation patients: 8 years of experience at a single institution.

作者信息

Liem Spencer, Cavarocchi Nicholas C, Hirose Hitoshi

机构信息

Thomas Jefferson University, Philadelphia, PA, USA.

Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA.

出版信息

Perfusion. 2020 Jan;35(1):73-81. doi: 10.1177/0267659119860735. Epub 2019 Jul 12.

Abstract

INTRODUCTION

Post-cardiac arrest survivals remain low despite the effort of cardiopulmonary resuscitation. Utilization of extracorporeal membrane oxygenation during cardiopulmonary resuscitation (extracorporeal cardiopulmonary resuscitation) can provide immediate cardiovascular support and potentially improve outcomes of patients with cardiac arrest requiring cardiopulmonary resuscitation. There is renewed interest in the use of extracorporeal cardiopulmonary resuscitation due to improved outcomes over the years.

METHODS

Extracorporeal membrane oxygenation data between 2010 and 2018 were reviewed. Patients with extracorporeal membrane oxygenation placed under cardiopulmonary resuscitation were identified, and demographics, extracorporeal membrane oxygenation survival, survival to discharge, and neurological recovery were retrospectively analyzed with institutional review board approval.

RESULTS

Among 230 cases of extracorporeal membrane oxygenation, 34 (21 males and 13 females, age of 49 ± 13 years) underwent extracorporeal cardiopulmonary resuscitation. The mean duration of extracorporeal membrane oxygenation support after extracorporeal cardiopulmonary resuscitation was 8.3 ± 7.9 days. Extracorporeal membrane oxygenation mortality among extracorporeal cardiopulmonary resuscitation patients was 32% (11/34) and hospital survival was 38% (13/34), which are similar to standard cardiac extracorporeal membrane oxygenation (extracorporeal membrane oxygenation survival 62% and hospital survival 39% in cardiac extracorporeal membrane oxygenation). Among the extracorporeal membrane oxygenation death after extracorporeal cardiopulmonary resuscitation, the majority was due to neurological injury (73%, 8/11); 8/34 extracorporeal membrane oxygenation survival rate and 30-day survival rate were 63% and 25% in early half of study (2010-2014) and have improved to 70% and 60% in late half of study (2014-2018).

CONCLUSION

Over years of experience with extracorporeal membrane oxygenation, the outcome of the extracorporeal cardiopulmonary resuscitation has been improving and appears to exceed those of traditional methods, despite limited sample size. Neurological complications still need to be addressed in order for survival and outcomes to improve.

摘要

引言

尽管进行了心肺复苏,但心脏骤停后的存活率仍然很低。在心肺复苏期间使用体外膜肺氧合(体外心肺复苏)可以立即提供心血管支持,并有可能改善需要心肺复苏的心脏骤停患者的预后。由于多年来预后有所改善,人们对使用体外心肺复苏重新产生了兴趣。

方法

回顾了2010年至2018年期间的体外膜肺氧合数据。确定了在心肺复苏期间接受体外膜肺氧合的患者,并在机构审查委员会批准后,对人口统计学、体外膜肺氧合存活情况、出院存活率和神经功能恢复情况进行了回顾性分析。

结果

在230例体外膜肺氧合病例中,34例(男性21例,女性13例,年龄49±13岁)接受了体外心肺复苏。体外心肺复苏后体外膜肺氧合支持的平均持续时间为8.3±7.9天。体外心肺复苏患者的体外膜肺氧合死亡率为32%(11/34),住院存活率为38%(13/34),这与标准心脏体外膜肺氧合情况相似(心脏体外膜肺氧合的体外膜肺氧合存活率为62%,住院存活率为39%)。在体外心肺复苏后发生的体外膜肺氧合死亡病例中,大多数是由于神经损伤(73%,8/11);在研究的前半期(2010 - 2014年),34例中有8例的体外膜肺氧合存活率和30天存活率分别为63%和25%,而在研究的后半期(2014 - 2018年)已分别提高到70%和60%。

结论

经过多年体外膜肺氧合的经验,尽管样本量有限,但体外心肺复苏的预后一直在改善,并且似乎超过了传统方法。为了提高存活率和改善预后,仍需要解决神经并发症问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验